HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
H H Zhu Selected Research
H H Zhu Research Topics
Disease
6
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
05/2019 - 03/2016
4
Leukemia
01/2018 - 06/2016
3
Neoplasm Metastasis (Metastasis)
05/2022 - 03/2016
2
Hepatic Echinococcosis
08/2021 - 10/2019
2
Hepatocellular Carcinoma (Hepatoma)
04/2020 - 06/2017
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
08/2018 - 06/2016
2
Prostatic Neoplasms (Prostate Cancer)
11/2017 - 03/2016
1
Hypothyroidism
07/2023
1
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2022
1
Fibrosis (Cirrhosis)
08/2021
1
Ascites
04/2020
1
Lymphatic Metastasis
04/2020
1
Infections
01/2020
1
Myelodysplastic Syndromes (Myelodysplastic Syndrome)
09/2018
1
Neoplasms (Cancer)
11/2017
1
Hypercholesterolemia
04/2014
1
Carotid Artery Diseases
04/2014
1
Chronic Hepatitis B
08/2013
1
Massive Hepatic Necrosis
08/2013
1
Hepatitis B
08/2013
1
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
08/2008
Drug/Important Bio-Agent (IBA)
2
Proteins (Proteins, Gene)
FDA Link
08/2021 - 03/2016
2
Cytarabine (Cytosar-U)
FDA Link
Generic
09/2018 - 01/2018
1
Plax
IBA
07/2023
1
Biomarkers (Surrogate Marker)
IBA
05/2022
1
B7-H1 Antigen
IBA
05/2022
1
Immune Checkpoint Inhibitors
IBA
05/2022
1
Bone Morphogenetic Protein 7
IBA
08/2021
1
Contrast Media
IBA
04/2020
1
Gelatin
IBA
04/2020
1
Cellophane
IBA
01/2020
1
Aclarubicin
IBA
09/2018
1
Granulocyte Colony-Stimulating Factor (G-CSF)
IBA
09/2018
1
Decitabine
FDA Link
09/2018
1
Daunorubicin (Cerubidine)
FDA Link
Generic
08/2018
1
Idarubicin (4 Demethoxydaunorubicin)
FDA Link
Generic
01/2018
1
Antisense RNA (Anti-Sense RNA)
IBA
11/2017
1
Androgens
IBA
11/2017
1
Messenger RNA (mRNA)
IBA
10/2017
1
Polypyrimidine Tract-Binding Protein
IBA
06/2017
1
Monoclonal Antibodies
IBA
06/2017
1
MicroRNAs (MicroRNA)
IBA
06/2017
1
3,4- dihydro- alpha,alpha- dimethyl- beta- ethyl- 6- methoxy- 2-naphthalenepropionic acid
IBA
06/2017
1
Sorafenib (BAY 43-9006)
FDA Link
12/2016
1
C-Reactive Protein
IBA
04/2014
1
oxidized low density lipoprotein
IBA
04/2014
1
Ezetimibe (Zetia)
FDA Link
04/2014
1
Atorvastatin (Lipitor)
FDA Link
04/2014
1
Lipids
IBA
04/2014
1
Mucins
IBA
08/2013
1
Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)
IBA
08/2013
1
Bilirubin
IBA
08/2013
1
Alanine Transaminase (SGPT)
IBA
08/2013
1
Chemokine CXCL2
IBA
08/2013
1
Imatinib Mesylate (Gleevec)
FDA Link
08/2008
Therapy/Procedure
4
Induction Chemotherapy
08/2018 - 03/2016
3
Drug Therapy (Chemotherapy)
10/2019 - 07/2017
2
Therapeutics
05/2019 - 11/2017
1
Immunotherapy
05/2022
1
Liver Transplantation
10/2019
1
Palliative Care (Palliative Therapy)
10/2019
1
CAG protocol
09/2018
1
Hematopoietic Stem Cell Transplantation
01/2018
1
Castration
11/2017
1
Maintenance Chemotherapy
06/2016
1
Aftercare (After-Treatment)
04/2014